These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33388822)

  • 1. Metabolic diversity as a reason for unsuccessful detoxification from benzodiazepines: the rationale for serum BZD concentration monitoring.
    Basińska-Szafrańska A
    Eur J Clin Pharmacol; 2021 Jun; 77(6):795-808. PubMed ID: 33388822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed crises following benzodiazepine withdrawal: deficient adaptive mechanisms or simple pharmacokinetics? Detoxification assisted by serum-benzodiazepine elimination tracking.
    Basińska-Szafrańska A
    Eur J Clin Pharmacol; 2022 Jan; 78(1):101-110. PubMed ID: 34515812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a long-acting substitute in detoxification from benzodiazepines: safety (accumulation) problems and proposed mitigation procedure.
    Basińska-Szafrańska A
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1833-1841. PubMed ID: 36114834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.
    Stein MD; Kanabar M; Anderson BJ; Lembke A; Bailey GL
    J Subst Abuse Treat; 2016 Sep; 68():57-61. PubMed ID: 27431047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine tapering: a prospective study.
    Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
    Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands.
    Beurmanjer H; Luykx JJ; De Wilde B; van Rompaey K; Buwalda VJA; De Jong CAJ; Dijkstra BAG; Schellekens AFA
    CNS Drugs; 2020 Jun; 34(6):651-659. PubMed ID: 32319006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review.
    Morera-Fumero AL; Fernandez-Lopez L; Abreu-Gonzalez P
    Drug Alcohol Depend; 2020 Jul; 212():107994. PubMed ID: 32409111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly.
    Puustinen J; Nurminen J; Kukola M; Vahlberg T; Laine K; Kivelä SL
    Drugs Aging; 2007; 24(12):1045-59. PubMed ID: 18020536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life.
    Curran HV; Collins R; Fletcher S; Kee SC; Woods B; Iliffe S
    Psychol Med; 2003 Oct; 33(7):1223-37. PubMed ID: 14580077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approach for detoxification of patients dependent on benzodiazepines and Z-drugs for reduction of psychogenic complications.
    Kubová K; Franc A; Vysloužil J; Šaloun J; Vetchý D
    Ceska Slov Farm; 2019; 68(4):139-147. PubMed ID: 31822106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected].
    Davies J; Rae TC; Montagu L
    Br J Gen Pract; 2017 Sep; 67(662):e609-e613. PubMed ID: 28716996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benzodiazepine or non-benzodiazepine hypnotics withdrawal syndrome during hospitalization: A series of 22 cases].
    Thorel M; Fummi C; Gras V; Masmoudi K
    Therapie; 2016 Jun; 71(3):323-8. PubMed ID: 27235656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine harm: how can it be reduced?
    Lader M
    Br J Clin Pharmacol; 2014 Feb; 77(2):295-301. PubMed ID: 22882333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine treatment for alcohol-dependent patients.
    Lejoyeux M; Solomon J; Adès J
    Alcohol Alcohol; 1998; 33(6):563-75. PubMed ID: 9872344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?
    Jobert A; Laforgue EJ; Grall-Bronnec M; Rousselet M; Péré M; Jolliet P; ; Feuillet F; Victorri-Vigneau C
    Eur J Clin Pharmacol; 2021 Feb; 77(2):171-177. PubMed ID: 33006626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use.
    Tseng LY; Huang ST; Peng LN; Chen LK; Hsiao FY
    Neurotherapeutics; 2020 Jan; 17(1):156-164. PubMed ID: 31802436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The problems with the use of benzodiazepines in elderly patients].
    Bourin M
    Encephale; 2010 Sep; 36(4):340-7. PubMed ID: 20850606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder.
    Stein MD; Anderson BJ; Kenney SR; Bailey GL
    J Subst Abuse Treat; 2017 Jun; 77():67-71. PubMed ID: 28476275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.